Immunome, Inc.

NASDAQ:IMNM

12.54 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -106.806-36.896-24.711-17.837-10.444-7.845
Depreciation & Amortization 0.7280.6310.7550.7550.6150.521
Deferred Income Tax 0-7.271-0.55.53800
Stock Based Compensation 6.2235.3323.4480.6210.0140.011
Change In Working Capital 11.9972.2432.778-1.2090.212-0.102
Accounts Receivables 000000
Inventory 000000
Accounts Payables -0.608-0.6771.780.5040.0750.146
Other Working Capital 12.6052.920.998-1.7130.137-0.248
Other Non Cash Items 88.5777.2710.004-0.0020.0030.009
Operating Cash Flow -7.568-28.69-18.226-12.134-9.6-7.406
Investing Activities:
Investments In Property Plant And Equipment -0.831-0.248-0.079-0.586-0.233-0.228
Acquisitions Net 9.27600000
Purchases Of Investments -38.92900000
Sales Maturities Of Investments 000000
Other Investing Activites 9.27600000
Investing Cash Flow -30.484-0.248-0.079-0.586-0.233-0.228
Financing Activities:
Debt Repayment 00-0.113-0.451-0.612-0.551
Common Stock Issued -8.5920.03227.88144.854.6210
Common Stock Repurchased 000-0.049-0.0350
Dividends Paid 000000
Other Financing Activities 116.4080.03227.8815.64211.4210
Financing Cash Flow 116.4080.03227.76849.94310.774-0.551
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 78.356-28.9069.46337.2230.941-8.185
Cash At End Of Period 98.67920.42349.32939.8662.6431.702